National
Agri-Women Focus on Maine’s Growth Potential
Highlights local company improving animal health by reducing the use of antibiotics
SOUTH PORTLAND – Maine
Agri-Women are hosting the annual American Agri-Women convention in South Portland
at the DoubleTree Hotel, Nov. 5-8, 2015. AAW is the largest coalition of
farm, ranch and agribusiness affiliated organizations throughout the country. The
organization works to ensure a safe, reliable and affordable food, fiber and
fuel supply.
Tour and Reception: Agri-Women
will tour ImmuCell of Portland, Maine today and take part in a reception
starting at 2 p.m. The tour and reception will also include Maine Agricultural,
Conservation and Forestry (DACF) Commissioner Walt Whitcomb and state
agricultural officials.
“It is great that a national group of this
caliber is visiting an innovative Maine company that is taking the lead in
reducing dependence on antibiotics for food production,” said DACF Walt Whitcomb.
“We are very excited that our state is hosting a celebration of American
Agri-Women’s 40th year advocating for agriculture in Maine and
nationally.”
American
Agri-Women (AAW) is the nation’s largest coalition of farm,
ranch and agribusiness women with more than 50 state, commodity and
agribusiness affiliate organizations throughout the country. AAW members have
been advocating for agriculture since 1974 and are now celebrating their 40th
anniversary.
AAW has been celebrating its 40th anniversary
DRIVE ACROSS AMERICA. AAW visited and educated consumers about American grown
food and fiber and visited with AAW affiliates and members along the way. It
has been a great way to recognize and honor the important role that women play
in American Agriculture and to develop a stronger network between American
agriculturalists and consumers. After highlighting the exceptional
agricultural, food and fiber system in the U.S., the DRIVE concludes at the national
convention at the Double Tree in South Portland, Maine.
ImmuCell is a public biotechnology company that is developing,
manufacturing and selling products that improve animal health and productivity
in the dairy and beef industries. Their product focus encompasses prevention,
diagnosis and treatment of economically important bovine diseases. ImmuCell is
a publically held company that trades on NASDAQ under the ticker symbol ICCC.
Some examples of ImmuCell products:
- ImmuCell’s 85 employees have protected 16
million calves with their First Defense product since it hit the market. First
Defense provides calves immediate immunity, thereby reducing dependence on
treatment antibiotics and maximizing a calf’s genetic potential. First Defense
in sold in the US, Canada, Japan, Korea, and China.
- ImmuCell is in the final stages of FDA approval
for a product that would treat subclinical mastitis in dairy cows (Mast Out). It
is unusual that a company of ImmuCell’s size invests to take a new product
through the FDA approval process – but they are doing just that with Mast Out, their
intra-mammary treatment for subclinical mastitis. Currently a producer’s only
option is to treat mastitis with antibiotics.
A. Since there are no antibiotics allowed in our food
supply, producers are required to dump the milk of treated cows down the drain
rather than sell it.
B. Because the active ingredient in Mast Out is not an
antibiotic (it’s a naturally occurring food preservative that we’ve further
purified), producers would be able to treat mastitis and sell the milk/meat
since it is safe.
For more information on American Agri-Women: http://www.americanagriwomen.org/
For
more information on Immucell: http://www.immucell.com
| 
